Disease Awareness Ads Must Be Different, Distant From Branded Ads, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is encouraging the use of disease awareness advertisements but warns that ads too similar or shown too close together with branded spots could result in product withdrawal.You may also be interested in...
Guidance On Outdoor Promotion Will Formalize "Traditional" Approach – FDA
A draft guidance on outdoor promotion will formalize the Division of Drug Marketing, Advertising & Communications' "traditional" approach to reviewing the advertisements, Director Thomas Abrams said
Guidance On Outdoor Promotion Will Formalize "Traditional" Approach – FDA
A draft guidance on outdoor promotion will formalize the Division of Drug Marketing, Advertising & Communications' "traditional" approach to reviewing the advertisements, Director Thomas Abrams said
FDA Should Allow Linkages Between "Help-Seeking" and Full Product Ads, Pfizer Says
Similarities between disease awareness ads and full product ads, which contain risk information, could benefit consumers, Pfizer says in comments on FDA's draft DTC guidance. The company is working with consumer and medical groups to generate such evidence.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: